Nordic Bioproducts Group opens its first major production facility for advanced cellulosic materials
Finnish startup Nordic Bioproducts Group has opened its state-of-the-art production facility in Lappeenranta, Finland. This facility, powered by the company’s proprietary AaltoCell™ Technology, is dedicated to the commercial-scale production of advanced cellulosic materials, including its flagship Microcrystalline Cellulose (MCC). The factory is expected to create 40 million euros in revenue in the first full operating year.HELSINKI, Finland (April 24th, 2024) - Nordic Bioproducts Group (NBG) , a leader in biomaterial innovation and developer of proprietary